Contacts
Business description
Developing a Cure for Multiple Sclerosis
Scytel Research is developing a tolerogenic therapeutic vaccine to potentially control and reverse multiple sclerosis (MS) by covalently linking a disease-specific cytokine and a myelin-specific neuro-antigen to create a recombinant fusion protein. This approach provides localized immune reaction in contrast to generalized immunosuppression that is experienced with current drug therapies for MS. The cytokine moiety not only directs the neuroantigen molecule to specific T cells but also modulates antigen presenting cell function to confer tolerogenic memory to T cells. The vaccine has proved to be efficacious in the rat EAE animal model for MS.
General information
Estimated number of employees: | 2 to 4 | |
City / suburb: | Chapel Hill, NC | |
County: | Orange |
tolerogenic therapeutic vaccine
Is this your business? Claim this profile to get thousands of free views!
QR code with Scytel Inc contacts
Reviews
Be the first to write a review about your experience with the company.
More details about this business
Or try our search form or quick navigation by category and location
Legal Counsel and Prosecution
Food Stores
Government Library